rituximab-GDP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rituximab-GDP, covering 2018-10-25 to 2018-10-25. Get the full timeline:
Most recent: Clinical Trial Update: Azacitidine and Rituximab-GDP Immunochemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 2]